Nanomix Corporation (NNMX) closed the last session at $0.1500 after seeing a rise of 731.02% that brought its market cap to $137.54M. The NNMX stock traded 23.22M shares recently, greater than its average daily volume of 199.49K. In addition, the NNMX shares have been trading in a range of $0.0196 to $0.1870. The pink sheets NNMX has 916.91M shares outstanding vs 72.12M float. As NNMX was highly upbeat in the absence of current news, recent developments might give more insight into the NNMX.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Did anything happen as of late at NNMX?
Nanomix is the forerunner in the advancement of versatile place of-care diagnostics with its Nanomix eLab stage and examines that give fast, precise, quantitative data for use in settings where time is basic to clinical direction and worked on tolerant consideration. NNMX’s items are intended to extensively affect medical care conveyance by carrying diagnostics to the mark of beginning patient association, regardless of whether in the clinic or in pre-clinic, remote or substitute consideration settings, with the objective to empower quicker clinical navigation and possibly therapy set up.
Nanomix as of late got affirmation of enlistment from the Medicines and Healthcare items Regulatory Agency (MHRA) of the United Kingdom for the Nanomix eLab framework and the S1 Panel Cartridge.
- The Nanomix eLab analyzer with S1 Panel Cartridge gives numerous host-reaction biomarker results that can help medical services suppliers in diagnosing and treating patients with basic diseases, including sepsis.
- The Nanomix eLab is a portable, hand-held immunoassay and science analytic framework.
- The Nanomix eLab offers the advantages of results in minutes, minimal expense, and transportability while giving exact, quantitative outcomes practically identical in quality to those given by focal lab testing.
- The Nanomix eLab S1 Panel Cartridge is a completely contained, expendable cartridge innovation containing reagents and biosensors that give quantitative estimation of two biomarkers, C-receptive protein (CRP) and Procalcitonin (PCT) and the metabolite Lactate (LAC), every one of which might be utilized in the assessment of basic diseases.
- NNMX item gives test to-answer results that can be utilized by medical care suppliers to help decision making on anti-infection treatment for patients with suspected or affirmed sepsis as well as suspected or affirmed lower respiratory parcel diseases (LRTI).
- The Nanomix eLab S1 Panel Cartridge has gotten CE Mark and MHRA Registration.
For what reason was the enrollment significant for NNMX?
The enrollment is a significant stage in speeding up the presentation and accessibility of Nanomix (NNMX) items to business sectors and patients all through the United Kingdom. NNMX’s S1 Panel gives numerous test results from a solitary patient example and a solitary cartridge in under 11 minutes. NNMX targets opportune diagnostics by the bedside to further develop treatment and change of care choices in both Point-of-Care and Hospital settings.